VEGF165 Protein, Human, Cynomolgus, Recombinant, HPLC-verified sinobiological 11066-HNAH

$4,283.00
In stock
SKU
11066-HNAH
Catalog No.SizePrice (USD)
11066-HNAH-11 mg$4,440.36
11066-HNAH-55 µg$100.72
11066-HNAH-2020 µg$367.31
11066-HNAH-100100 µg$737.59
11066-HNAH-500500 µg$1,907.67

General Information

FormulationLyophilized from sterile 20mM Tris, 150mM NaCl, pH 8.0 Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Endotoxin< 10 EU per mg protein.
ShippingIn general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & StorageSamples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
ReconstitutionTo find reconstitution info, click on 'COA' at the top of the page, enter the lot number and product size for the lot-specific COA.
Purity≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC. ≥ 95 % as determined by SEC-MALS(Routinely tested).
Activity1.iPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested) 2. Measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED 50 for this effect is typically 2-10 ng/mL. 3. Labeled biotin to VEGF165 Protein, Human / Cynomolgus, Recombinant by a certain molar ratio; Using the Octet RED System, the affinity constant (Kd) of VEGF165 Protein, Human / Cynomolgus, Recombinant, Biotinylated(Cat:11066-HNAH-B) bound to Avastin was 0.1 nM. 4. Anti-VEGF (Research Grade Bevaciz*mab Biosimilar) captured on Protein A chip can bind Recombinant Human, Cynomolgus VEGF165 Protein (Cat. No. 11066-HNAH) with an affinity constant of 14.9 pM as determined in an SPR assay (Biacore 8K) (Routinely tested). 5.Loaded Biotinylated Recombinant Human VEGFR1/FLT1 Protein, His & AVI Tag (Cat. No. 10136-H49H-B) on SA Biosensor, can bind Recombinant VEGF165 Protein, Human, Cynomolgus (Cat. No. 11066-HNAH) with an affinity constant of 0.506 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested).
Protein ConstructionA DNA sequence encoding the human / cynomolgus VEGF165 isoform (P15692-4) (Met1-Arg191) was expressed. Human and Cynomolgus VEGF165 sequences are identical.
Accession#P15692-4
Expressed HostHEK293 Cells
SpeciesHuman, Cynomolgus
Predicted N TerminalAla 27
Molecule MassThe recombinant human / cynomolgus VEGF165 consists of 165 amino acids and predicts a molecular mass of 19.2 KDa. It migrates as an approximately 22 kDa and 24 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 44.9 kDa verified by SEC-MALS(Routinely tested).

Image / Experimental Information

Image 1 DescriptioniPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested)
Image 1 Alt TextHuman FGF2 Protein 35969
Image 1 URLSource image
Image 2 DescriptioniPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested)
Image 2 Alt TextHuman, Cynomolgus VEGF-A Protein 41736
Image 2 URLSource image
Image 3 DescriptioniPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested)
Image 3 Alt TextHuman VEGFR1/FLT1 Protein 42961
Image 3 URLSource image
Image 4 DescriptioniPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested)
Image 4 Alt TextHuman, Cynomolgus VEGF-A Protein 49200
Image 4 URLSource image
Image 5 DescriptioniPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested)
Image 5 Alt TextHuman VEGF/VEGFA/VEGF165 Protein 9365
Image 5 URLSource image

Background Information

Full Namevascular endothelial growth factor A
DescriptionVascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.
Research Areas
  • Cancer Drug Targets
Related Pathways
  • VEGF Signaling Pathway
Tags
  • Cancer Immunotherapy
  • Immune Checkpoint
  • Immunotherapy
  • Targeted Therapy
References
  1. Woolard J. et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64(21): 7822-7835.
  2. Jia SF, et al. (2008) VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. J Exp Ther Oncol. 7(2): 89-97.
  3. Cimpean AM, et al. (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol. 49(3): 303-8.
  4. Hamdollah Zadeh MA, et al. (2008) VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation. 15(7): 605-14.
  5. Eisenach PA, et al. (2010) MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. 123(Pt 23):4182-4193.
  6. Claesson-Welsh L (2010) Gremlin: vexing VEGF receptor agonist. Blood. 116(18):3386-7.

title: Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine.
authors: Huaigeng Xu; Chisato Kamei; ...; Robert Blelloch
journal: Cell Stem Cell
date: 2026-08-25
pmid: 42641609
doi: 10.1016/j.stem.2026.07.017
cited_by_count: 0
techniques: Activation Assay; Blocking Assay; Cell Fractionation; Cell Isolation; Clinical Proteomics; Disruption; Filtration; Isolation; Membrane; Recombinant; Red Blood Cell Lysis; Selection
bioz_score: 95

title: TAL1 is indispensable in ETV2-primed human endothelial cell fate determination.
authors: Yun Zhao; Mengze Sun; ...; Kai Wang
journal: Science Advances
date: 2026-08-12
pmid: 42585327
doi: 10.1126/sciadv.aef9769
cited_by_count: 0
techniques: Cell Culture
bioz_score: 95

title: Recombinant protein targeting PD-L1 and VEGF and compositions thereof
authors: Wenzhi Tian; Song Li
date: 2026-01-20
cited_by_count: 0
techniques: Binding Assay; Control; Enzyme-linked Immunosorbent Assay; Incubation; Recombinant
bioz_score: 95

title: IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy
authors: Dianze Chen; Zhuli Wu; ...; Wenzhi Tian
journal: Antibody Therapeutics
date: 2026-01-01
pmid: 41804385
cited_by_count: 0
techniques: Activity Assay; Binding Assay; Blocking Assay; Control; Enzyme-linked Immunosorbent Assay; Flow Cytometry; Inhibition; Mlr Assay; Produced; Recombinant; Reporter Assay
bioz_score: 95

title: Gamma-synuclein drives bevacizumab resistance in colorectal cancer via VEGFR2 activation and angiogenesis.
authors: Caiyun Liu; Lin Meng; ...; Chengchao Shou
journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
date: 2025-12-09
pmid: 40939487
doi: 10.1016/j.drup.2025.101299
cited_by_count: 1
bioz_score: 95

title: Humanized anti-VEGF antibody Fab fragment
authors: Liangzhi Xie; Chunyun Sun; ...; Desheng Kong
date: 2025-11-25
cited_by_count: 0
techniques: Binding Assay; Blocking Assay; Recombinant
bioz_score: 95

title: Niche Environment Remodeling Promotes Long-Term Endometrium Stromal Stem Cell Engraftment and Tissue Regeneration in Thin Endometrium.
authors: Ninuo Xia; Jie Li; ...; Fang Fang
journal: Molecular therapy : the journal of the American Society of Gene Therapy
date: 2025-10-31
pmid: 41176621
doi: 10.1016/j.ymthe.2025.10.053
cited_by_count: 1
techniques: Control; Negative Control; Recombinant; Scratch Wound Assay Assay; Sterility; Transfection; Transferring
bioz_score: 95

title: Glycosylation-enabled chemoselective growth factor engineering for biomaterial functionalization.
authors: Yunhui Xing; Qingyang Li; ...; Xi Ren
journal: Acta Biomaterialia
date: 2025-10-01
pmid: 41043672
doi: 10.1016/j.actbio.2025.09.057
cited_by_count: 1
techniques: Binding Assay
bioz_score: 95

title: Engineered Subcutaneous Site for Optimal Organoid Transplantation
journal: Engineering
date: 2025-10-01
doi: 10.1016/j.eng.2025.10.016
cited_by_count: 0
techniques: Cell Culture; Confocal Microscopy; Control; Modification; Transfection; Transplantation Assay
bioz_score: 95

title: G6PD deficiency is implicated in Circle of Willis variants in stroke patients and impairs brain vasculature in zebrafish
authors: Yuangui Cai; Jianle Li; ...; Jinsheng Zeng
journal: Journal of Cerebral Blood Flow & Metabolism
date: 2025-09-25
pmid: 40995861
doi: 10.1177/0271678X251377678
cited_by_count: 0
techniques: Recombinant
bioz_score: 95

title: Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents
authors: Zhongyu Zhang; Zhengde Zhao; ...; Sifan Chen
journal: Nature Communications
date: 2025-08-07
pmid: 40775187
doi: 10.1038/s41467-025-62320-w
cited_by_count: 1
techniques: Concentration Assay; Electron Microscopy; Enzyme-linked Immunosorbent Assay; In Vitro; Transmission Assay
bioz_score: 95

title: Anti-angiogenesis enhances the tumor immunotherapeutical effect of recombinant CD80 fusion protein.
authors: Songna Wang; Litao Huang; ...; Li Ye
journal: International Journal of Biological Macromolecules
date: 2025-07-27
pmid: 40730308
doi: 10.1016/j.ijbiomac.2025.146350
cited_by_count: 0
techniques: Binding Assay
bioz_score: 95

title: A costal-cartilage derived stem cell-laden prominin-1-derived peptide collagen hydrogel for angiogenesis and bone regeneration.
authors: Chenhui Cai; Rui Zuo; ...; Chao Zhang
journal: Acta Biomaterialia
date: 2025-07-10
pmid: 40651591
doi: 10.1016/j.actbio.2025.07.023
cited_by_count: 8
techniques: Concentration Assay; In Vitro
bioz_score: 95

title: Gamma-synuclein promotes Bevacizumab resistance by activating vascular endothelial growth factor receptor in colorectal cancer
authors: Caiyun liu; Lixin Wang; ...; chengchao shou
journal: Research Square
date: 2024-11-27
doi: 10.21203/rs.3.rs-5414606/v1
cited_by_count: 0
techniques: Cell Culture; Isolation
bioz_score: 94

title: Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery.
authors: Zihang Pan; Qiyang Yao; ...; Kai Wang
journal: Cell Stem Cell
date: 2024-11-22
pmid: 39579761
doi: 10.1016/j.stem.2024.10.015
cited_by_count: 32
techniques: Recombinant
bioz_score: 95

title: Development of bioassay platforms for biopharmaceuticals using Jurkat-CAR cells by AICD.
authors: Dianze Chen; Song Li; ...; Wenzhi Tian
journal: Journal of Pharmaceutical and Biomedical Analysis
date: 2024-08-22
pmid: 39197208
doi: 10.1016/j.jpba.2024.116431
cited_by_count: 1
techniques: CCK-8 Assay; Proliferation Assay
bioz_score: 95

title: Humanized anti-VEGF monoclonal antibody
authors: Liangzhi Xie; Chunyun Sun; ...; Xiao Zhang
date: 2024-08-13
cited_by_count: 0
techniques: Adjuvant; Binding Assay; Blocking Assay; Recombinant; Sequencing
bioz_score: 95

title: Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models
authors: Yeri Lee; Donggeon Kim; ...; Byoung Chul Lee
journal: Ophthalmology and therapy
date: 2024-06-21
pmid: 38907092
pmcid: 11246403
cited_by_count: 3
techniques: Activity Assay; Bioassay; Blocking Assay; Concentration Assay; Construct; Expressing; Functional Assay; Hemolysis Assay; In Vitro; Incubation; Luciferase; Reporter Assay
bioz_score: 95

title: Granular Biomaterials as Bioactive Sponges for the Sequestration and Release of Signaling Molecules.
authors: Dilara Börte Emiroglu; Apoorv Singh; ...; Mark W Tibbitt
journal: Advanced Healthcare Materials
date: 2024-05-29
pmid: 38808536
doi: 10.1002/adhm.202400800
cited_by_count: 5
techniques: Enzyme-linked Immunosorbent Assay; Recombinant
bioz_score: 95

title: Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies.
authors: Debnath Maji; Verónica Miguela; ...; Rachel A Liberatore
journal: Pharmaceutics
date: 2024-04-17
pmid: 38675208
doi: 10.3390/pharmaceutics16040547
cited_by_count: 0
techniques: Blocking Assay; Clinical Proteomics; Concentration Assay; Enzyme-linked Immunosorbent Assay; Incubation; Recombinant
bioz_score: 95

title: Characterization of gene regulatory networks underlying key properties in human hematopoietic stem cell ontogeny
authors: Fei Li; Yanling Zhu; ...; Guangjin Pan
journal: Cell Regeneration
date: 2024-04-17
pmid: 38630195
doi: 10.1186/s13619-024-00192-z
pmcid: 11024070
cited_by_count: 5
bioz_score: 95

title: Rapid conversion of porcine pluripotent stem cells into macrophages with chemically defined conditions.
authors: Xiaolong Wu; Yu Ni; ...; Jinlian Hua
journal: The Journal of Biological Chemistry
date: 2024-02-08
pmid: 38097188
doi: 10.1016/j.jbc.2023.105556
cited_by_count: 7
bioz_score: 95

title: Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereof
authors: Yaping Yang; Nanmeng Song; ...; Maengsup Kim
date: 2023-11-28
cited_by_count: 0
techniques: Activity Assay; Binding Assay; Concentration Assay; Enzyme-linked Immunosorbent Assay; Incubation; Recombinant
bioz_score: 95

title: Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration.
authors: Shuqian Zhu; Shilong Fan; ...; Feng Qian
journal: Bioengineering & Translational Medicine
date: 2023-11-01
pmid: 38023710
cited_by_count: 4
techniques: High Performance Liquid Chromatography; Recombinant
bioz_score: 95

title: Recombinant protein targeting PD-L1 and VEGF
authors: Wenzhi Tian; Song Li
date: 2022-08-09
cited_by_count: 0
techniques: Binding Assay; Enzyme-linked Immunosorbent Assay; Incubation; Recombinant
bioz_score: 95

title: Integrative epigenomic and transcriptomic analysis reveals the requirement of JUNB for hematopoietic fate induction
authors: Xia Chen; Peiliang Wang; ...; Jie Na
journal: Nature Communications
date: 2022-06-06
pmid: 35668082
doi: 10.1038/s41467-022-30789-4
pmcid: 9170695
cited_by_count: 16
techniques: Cell Culture; Knock-Out; Stem Cell Culture
bioz_score: 95

title: A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics
authors: Torleif T. Gjølberg; Heidrun E. Lode; ...; Morten C. Moe
journal: Frontiers in Ophthalmology
date: 2022-05-04
doi: 10.3389/fopht.2022.882013
cited_by_count: 3
techniques: Binding Assay; Blocking Assay; Concentration Assay; Enzyme-linked Immunosorbent Assay; Incubation; Recombinant
bioz_score: 95

title: Droplet-Based Microfluidic Synthesis of Hydrogel Microparticles via Click Chemistry-Based Cross-Linking for the Controlled Release of Proteins.
authors: Casper H Y Chung; Chi Ming Laurence Lau; ...; Shuhuai Yao
journal: ACS Applied Bio Materials
date: 2022-04-08
pmid: 35006890
doi: 10.1021/acsabm.1c00509
cited_by_count: 4
techniques: Enzyme-linked Immunosorbent Assay; Functional Assay; Incubation
bioz_score: 95

title: Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model
authors: Peng Zhao; Yasuaki Anami; ...; Zhiqiang an
journal: mAbs
date: 2022-04-07
pmid: 35388745
doi: 10.1080/19420862.2022.2057269
pmcid: 8993059
cited_by_count: 14
techniques: Binding Assay; Construct; Flow Cytometry; Incubation; Labeling; Titration; Western Blot
bioz_score: 95

title: Chitosan Hydrogel Supplemented with Metformin Promotes Neuron–like Cell Differentiation of Gingival Mesenchymal Stem Cells
authors: Shanglin Cai; Tong Lei; ...; Lucia Santorelli
journal: International Journal of Molecular Sciences
date: 2022-03-18
pmid: 35328696
doi: 10.3390/ijms23063276
pmcid: 8955038
cited_by_count: 25
techniques: Modification
bioz_score: 95

title: A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
authors: Xiaopei Cui; Huifeng Jia; ...; Xuemei Zhang
journal: Frontiers in Immunology
date: 2021-12-02
pmid: 34925354
doi: 10.3389/fimmu.2021.778978
pmcid: 8678608
cited_by_count: 32
techniques: Binding Assay; Injection
bioz_score: 95

title: Modular fluorescent nanoparticle DNA probes for detection of peptides and proteins
authors: Cassandra M. Stawicki; Torri E. Rinker; ...; Parag Mallick
journal: Scientific Reports
date: 2021-10-07
pmid: 34620912
doi: 10.1038/s41598-021-99084-4
pmcid: 8497506
cited_by_count: 10
techniques: Binding Assay; Conjugation Assay; Negative Control; Recombinant; Sequencing; Synthesized
bioz_score: 95

title: Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells
authors: Liangjun Wang; Ning Chen; Hongxia Cheng
journal: Oncology Letters
date: 2020-08-01
pmid: 32724364
doi: 10.3892/ol.2020.11679
pmcid: 7377090
cited_by_count: 14
techniques: Concentration Assay; High Performance Liquid Chromatography; Inhibition; Negative Control
bioz_score: 95

title: A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis.
authors: Taha Azad; Kazem Nouri; ...; Xiaolong Yang
journal: Oncogene
date: 2020-04-17
pmid: 31477837
doi: 10.1038/s41388-019-0988-y
cited_by_count: 50
techniques: Incubation; Luciferase; Recombinant; Staining
bioz_score: 95

title: An efficient protein production system via gene amplification on a human artificial chromosome and the chromosome transfer to CHO cells
authors: Takahito Ohira; Koichi Miyauchi; ...; Hiroyuki Kugoh
journal: Scientific Reports
date: 2019-11-18
pmid: 31740706
doi: 10.1038/s41598-019-53116-2
pmcid: 6861226
cited_by_count: 6
techniques: Blocking Assay; Cell Culture; Clone Assay; Enzyme-linked Immunosorbent Assay; Incubation; Labeling; Molecular Weight; Plasmid Preparation; Purification; SDS Page; Silver Staining; Staining; Western Blot
bioz_score: 95

title: Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus
authors: Lei Chen; Xiaoyu Yang; ...; Weichang Yu
journal: Frontiers in Plant Science
date: 2016-08-09
pmid: 27555853
doi: 10.3389/fpls.2016.01156
pmcid: 4977302
cited_by_count: 18
techniques: Activity Assay; Binding Assay; Construct; Enzyme-linked Immunosorbent Assay; Incubation; Negative Control; Positive Control; Purification; Transgenic Assay
bioz_score: 95

title: Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study
authors: Yu Yu; Laurence Chi Ming Lau; ...; Ying Chau
journal: Translational Vision Science & Technology
date: 2015-03-10
pmid: 25774331
doi: 10.1167/tvst.4.2.5
pmcid: 4356035
cited_by_count: 95
techniques: Filtration; Purification
bioz_score: 95

Reviews

Write Your Own Review
You're reviewing:VEGF165 Protein, Human, Cynomolgus, Recombinant, HPLC-verified sinobiological 11066-HNAH
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.